Stop TB Partnership

November 2006: Jakarta, Indonesia

Meeting Documents

2.06-0 Outcomes

• Decision Points [.pdf]
• Presentations from the meeting - 18 MB [.zip]

2.06-00 Welcome

• 2.06-00 Agenda [.pdf]
• 2.06-00 Document List [.pdf]
• 2.06-00 List of Participants [.pdf]
• 2.06-00 Welcome [.pdf]

2.06-01 Opening Session

• 2.06-01.1 Decisions Points Abuja, Nigeria 24-25 April 2006 [.pdf]
• 2.06-01.2 Report 10th Stop TB Coordinating Board meeting [.pdf]
• 2.06-01.3 Abuja Action Plan Status [.pdf]

2.06-02 TB Control in South East Asia

• 2.06-02.0 TB in South-East Asia Summary Sheet [.pdf]

2.06-03 Call to Stop TB in Asia

• 2.06-03.0 Call to Stop TB in Asia Summary Sheet [.pdf]
• 2.06-03.1 Call to Stop TB in Asia - Reversing the Epidemic [.pdf]

2.06-04 Evaluation of the Stop TB Partnership in 2007

• 2.06-04.0 Evaluation of the Stop TB Partnership in 2007 Summary Sheet [.pdf]
• 2.06-04.1 Note for the Coordinating Board [.pdf]

2.06-05 XDR-TB Drug Resistance and Global Response

• 2.06-05.0 XDRTB Drug Resistance and Global Response Summary Sheet [.pdf]
• 2.06-05.1 Report of the meeting of the WHO Global Task Force on XDR-TB [.pdf]
• 2.06-05.2 Frequently asked questions - XDR-TB [.pdf]
• 2.06-05.3 XDR-TB Update Nov06 [.pdf]
• 2.06-05.4 Summary XDR-TB Response plan for Southern Africa 2006-2007 [.pdf]
• 2.06-05.5 Weekly Epi Report XDR-TB [.pdf]
• 2.06-05.6 WHO International health conference opens with XDR-TB US $95 million funding call [.htm]

2.06-06 World Bank Economic Impact Analysis of TB

• 2.06-06.0 World Bank Economic Impact Study Summary [.pdf]

2.06-07 Review of the Structure and Function of the Partnership's Working Groups

• 2.06-07.0 WG Review Summary Sheet [.pdf]
• 2.06-07.1 WG Review [.pdf]

2.06-08 Monitoring and Evaluating Implementation of the Global Plan to Stop TB (2006-2015)

• 2.06-08.0 M&E of implementation of the Global Plan [.pdf]
• 2.06-08.1 Framework for M&E of implementation of the Global Plan [.pdf]
• 2.06-08.2 Standard Template for M&E of Global Plan [.xls]

2.06-09 TB Research

• 2.06-09.0 TB Research Summary Sheet [.pdf]
• 2.06-09.1 Strategic Paper on Global Stop TB Research Movement [.pdf]
• 2.06-09.2 TAG Funding for Research Ex. Sum and Recommendations [.pdf]
• 2.06-09.3 Appendix A - Top 40 Reporting TB R&D Funders in 2005 [.pdf]
• 2.06-09.4 Appendix B - Actual or Potential TB R&D Funders not Reported on [.pdf]

2.06-10 Task Force on Retooling

• 2.06-10.0 Task Force on Retooling Summary Sheet [.pdf]
• 2.06-10.1 Retooling Task Force Workplan [.pdf]
• 2.06-10.2 New Technologies for TB Control - A Guide [.pdf]
• 2.06-10.3 TB Products in the pipeline [.pdf]

2.06-11 Diagnostics for TB

• 2.06-11.0 Diagnostics Summary Sheet [.pdf]
• 2.06-11.1 Diagnostics for TB Exec_sum [.pdf]

2.06-12 Financial Sustainability of GDF grant recipients

• 2.06-12.0 Financial Sustainability of GDF grant recipients Summary Sheet [.pdf]
• 2.06-12.1 The GAVI financial sustainability planning process [.pdf]
• 2.06-12.2 Building national drug management capacity while inducing financial sustainability [.pdf]
• 2.06-12.3 GDF Sustaining the Gains Strategy [.pdf]

2.06-13 Global Fund Engagement and Evaluation

• 2.06-13.0 Global Fund Summary Sheet [.pdf]
• 2.06-13.1 MOU with GFATM [.pdf]
• 2.06-13.2 TBTEAM [.pdf]

2.06-14 The Partners Forum

• 2.06-14.0 The Partners Forum Summary Sheet [.pdf]

2.06-15 ACSM

• 2.06-15.0 ACSM Summary Sheet [.pdf]
• 2.06-15.1 ACSM Organigram [.pdf]
• 2.06-15.2 Terms of Reference of the ACSM Working Group [.pdf]

2.06-16 Conclusions, Meetings and Missions

• 2.06-16.0 Conclusions, Meetings and High Level Missions Summary Sheet [.pdf]
• 2.06-16.1 Calendar of Meetings & Missions 2007 [.pdf]